Escapelle 1500 microgram tablet(Postinor)
1500 micrograms, tablet
Levonorgestrel
Escapelle 1500 microgram tablet and Postinor are different trade names for the same medicine.
Escapelle 1500 is an emergency contraceptive that can be used within 72 hours (3 days) after unprotected sex or when a contraceptive method has failed.
This applies to the following situations:
Escapelle 1500 contains a synthetic hormone called levonorgestrel as the active substance.
Taken within 72 hours after unprotected sex, the medicine prevents pregnancy in 84%.
It will not prevent pregnancy in every case, and its effectiveness is greater if taken as soon as possible after unprotected sex. It is best to take the medicine within the first 12 hours, rather than waiting until the third day after unprotected sex.
It is thought that Escapelle 1500 works by:
Escapelle 1500 prevents pregnancy only if taken within 72 hours after unprotected sex. The medicine is not effective if you are already pregnant.
If you have unprotected sex after taking Escapelle 1500 (also during the same menstrual cycle), the tablet may not work as a contraceptive, and you may be at risk of becoming pregnant again.
Escapelle 1500 is not indicated for use before the first menstrual bleeding (menarche).
If any of the following apply to you, you should tell your doctor before taking Escapelle 1500, as emergency contraception may not be suitable for you. Your doctor may prescribe a different type of emergency contraception for you.
You may already be pregnant if:
It is not recommended to take Escapelle 1500 if:
A history of ectopic pregnancy or fallopian tube inflammation increases the risk of another ectopic pregnancy.
All women should use emergency contraception as soon as possible after unprotected sex. There is evidence that Escapelle 1500 may be less effective with increasing body weight or body mass index (BMI), but the data are limited and inconclusive. Therefore, Escapelle 1500 is still recommended for all women, regardless of their weight or BMI.
If you have any doubts about using emergency contraception, you should consult a doctor, pharmacist, or nurse.
Escapelle 1500 is not indicated for use before the first menstrual bleeding (menarche).
If you did not use a condom (or it was damaged or slipped), you may be at risk of contracting a sexually transmitted disease or HIV.
This medicine does not protect against sexually transmitted diseases. Only the use of condoms can protect against infection. If you have any doubts, you should consult a doctor, nurse, family planning specialist, or pharmacist.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Some medicines may reduce the effectiveness of Escapelle 1500. If you have taken any of the following medicines in the last 4 weeks, Escapelle 1500 may not be suitable for you.
Your doctor may prescribe a different type of emergency contraception (non-hormonal), such as a copper intrauterine device (Cu-IUD). If this does not apply to you or you cannot see a doctor immediately, you can take a double dose of Escapelle 1500 (i.e., 2 tablets at the same time).
For further information on the correct dose, you should consult your doctor or pharmacist.
After taking the tablets for further advice on regular contraception and to rule out pregnancy, you should consult your doctor or pharmacist as soon as possible (see also section 3 "How to take Escapelle 1500").
Escapelle 1500 may also affect the action of other medicines:
Escapelle 1500 should only be used in emergency situations and not as a regular contraceptive method.
If Escapelle 1500 is used more than once in the same menstrual cycle, its contraceptive effect is weaker, and the risk of menstrual cycle disorders (menstruation) is higher.
Escapelle 1500 is not as effective as regular contraceptive methods. For information on long-term contraceptive methods that are more effective in preventing pregnancy, you should consult a doctor, nurse, or family planning specialist.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, you should consult your doctor or pharmacist before taking this medicine.
Pregnancy
Pregnant women should not take this medicine. If you become pregnant despite taking the medicine, it is essential to consult your doctor. There is no evidence that Escapelle 1500 has a harmful effect on the developing fetus if you take the medicine according to the instructions. However, your doctor will want to check that it is not an ectopic pregnancy (when the embryo develops outside the uterus). This is especially important if you experience severe abdominal pain after taking Escapelle 1500 or if you have had an ectopic pregnancy, had fallopian tube surgery, or had pelvic inflammatory disease.
Breastfeeding
The active substance of this medicine passes into breast milk. It is recommended that you take the tablet immediately after breastfeeding and then avoid breastfeeding for at least 8 hours after taking levonorgestrel and express milk from the breast during this time using a breast pump. By taking the tablet much earlier before the next breastfeeding, you can reduce the amount of active substance that may pass into your baby's body through breast milk.
Fertility
Taking Escapelle 1500 can increase the likelihood of menstrual disorders, which can sometimes lead to delayed or accelerated ovulation, affecting fertility. Since there is no data on the long-term effect on fertility, after taking Escapelle 1500, you should expect a rapid return to fertility.
Therefore, after taking Escapelle 1500, you should continue to use regular contraception or start using it as soon as possible.
It is unlikely that Escapelle 1500 will affect your ability to drive or use machines. However, if you feel tired or dizzy, you should not drive or operate machinery.
In cases of lactose intolerance, note that one Escapelle 1500 tablet contains 142.5 mg of lactose monohydrate.
If you have been diagnosed with an intolerance to some sugars, you should consult your doctor before taking the medicine.
This medicine should always be taken according to your doctor's instructions. If you have any doubts, you should consult your doctor or pharmacist.
The tablet should be taken as soon as possible, preferably within 12 hours, and no later than 72 hours (3 days) after unprotected sex. Do not delay taking the tablet. The sooner the tablet is taken after unprotected sex, the more effective it will be. The tablet can only prevent pregnancy if taken within 72 hours after unprotected sex.
If you have unprotected sex again (also during the same menstrual cycle) after taking Escapelle 1500, the tablet will not have a contraceptive effect, and you may be at risk of becoming pregnant again.
If you have any doubts about using emergency contraception, you should consult a doctor, pharmacist, or nurse.
If you vomit within 3 hours of taking the tablet, you should take another tablet immediately.
If you do not use contraceptive pills and plan to have sex after taking Escapelle 1500, you should use condoms or a diaphragm with spermicides until your next menstrual period. This is necessary because Escapelle 1500 is not effective in the event of another unprotected sexual encounter before your next menstrual period.
About 3 weeks after taking Escapelle 1500, you should have a medical check-up to ensure that the medicine has worked. If your menstrual bleeding is delayed by more than 5 days or you experience unusual bleeding, you should consult your doctor as soon as possible. If you become pregnant despite taking the medicine, it is essential to consult your doctor.
Your doctor may also provide information on long-term contraceptive methods that are more effective in preventing pregnancy.
If you continue to use regular hormonal contraception, such as the contraceptive pill, and do not experience menstrual bleeding during the pill-free period, you should consult your doctor to rule out pregnancy.
After taking Escapelle 1500, menstrual bleeding is usually normal and starts on the expected date, but it may start a few days later or earlier than usual. You may also experience irregular bleeding or spotting. If your menstrual bleeding is delayed by more than 5 days, or you experience unusual bleeding, you should consult your doctor as soon as possible.
Although no serious side effects have been reported when taking a large number of tablets at the same time, you may experience nausea, vomiting, and bleeding from the genital tract. You should consult a pharmacist, doctor, nurse, or family planning specialist, especially if you have vomited, as the tablet may not work.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any side effects, including any not listed in this leaflet, you should tell your doctor or pharmacist. You can report side effects directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Store in the original packaging to protect from light.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The tablet is almost white, flat, and about 8 mm in diameter, with the inscription "G00" on one side.
Packaging: one tablet in a PVC/Aluminum blister pack in a cardboard box.
For more detailed information, you should consult the marketing authorization holder or parallel importer.
Gedeon Richter Plc., Gyömrői út 19-21., 1103 Budapest, Hungary
Gedeon Richter Plc., Gyömrői út 19-21., 1103 Budapest, Hungary
InPharm Sp. z o.o., ul. Strumykowa 28/11, 03-138 Warsaw
InPharm Sp. z o.o. Services sp. k., ul. Chełmżyńska 249, 04-458 Warsaw
Marketing authorization number in Belgium, the country of export:BE285196
Austria: Postinor
Belgium: Postinor
France: Levonorgestrel Biogaran
Greece: Postinor
Spain: Postinor
Netherlands: Postinor
Ireland: Ramonna
Iceland: Postinor
Lithuania: Escapelle
Luxembourg: Postinor
Germany: Postinor
Norway: Postinor
Poland: Escapelle
Portugal: Postinor
Czech Republic: Escapelle
Sweden: Postinor
United Kingdom: Levonelle
Italy: Escapelle
Date of leaflet approval: 03.10.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.